David E. Bruns, M.D.

SOM Home > Clinical Departments > Pathology > Faculty > David E. Bruns, M.D.

David E. Bruns, M.D.

David E. Bruns, M.D. Faculty Profile

DavidBrunsPhoto.jpg

David E. Bruns, M.D.

Professor of Pathology

Director of Clinical Chemistry

Associate Director of Molecular Diagnostics

Co-Director, Fellowship in Clinical Chemistry and Laboratory Medicine


EDUCATION

Medical School: St. Louis University, MD, 1973

Residency and Fellowship: Departments of Pathology and Internal Medicine, Washington University, 1973-1977


CLINICAL

Clinical chemistry and molecular diagnostics.


RESEARCH

  • Quality requirements for medical tests

  • Harmonization of laboratory tests

 

RECENT BOOKS

  • Bruns DE, Ashwood ER, Burtis CA, eds. Fundamentals of Molecular Diagnostics. St. Louis: Saunders/Elsevier, 2007.

  • Burtis CA, Ashwood ER, Bruns DE, eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 5th ed., St. Louis: Saunders/Elsevier, 2012.

  • Burtis CA, Bruns DE, eds. Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics. 7th ed. St. Louis: Saunders/Elsevier, 2015

 

SELECTED REFERENCES

  • Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG,      Moher D, Rennie D, DeVet HC. Towards complete and accurate reporting of studies of      diagnostic accuracy: The STARD Initiative. Ann Intern Med 2003; 138:40-44 (and 14 other journals).
  • Sacks, DB, Arnold A, Bakris GL, Bruns DE, Horvath AR, Kirkman SK ,  Lernmark A, Metzger BE , Nathan DM. Executive summary: guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2011;57:793-8 and Diabetes Care 2011;34:1419-23.
  • Sacks DB, Bruns DE, Horton J, Lindberg S, Mahoney JJ, Manzella S, Reilly ET, Scott MG. Point-of-care blood glucose testing in acute and chronic care facilities: approved guideline. Clinical Laboratory Standards Institute 2013;33:1-48.
  • Algeciras-Schimnich A, Bruns DE, Boyd JC, Bryant S, La Fortune KA, Grebe SKG. Failure of current laboratory protocols to detect lot-to-lot reagent differences: Findings and possible solutions. Clin Chem 2013;59:1187-94. (Related Editorial: Bennett ST. Clin Chem 2013;59:1145-7).
  • Kelly BN, Haverstick DM, Lee JK, Thorner MO, Vance ML, Xin W, Bruns DE. Circulating microRNA as a biomarker of human growth hormone administration to patients. Drug Test Anal 2014;6:234-8. 
  • Mitsios JV, Ashby LA, Haverstick DM, Bruns DE, Scott MG. Analytic evaluation of a new glucose meter system in 15 different critical care settings. Diabetes Sci Technol 2013;7:1282-7.
  • Bachmann LM, Nilsson G, Bruns DE, McQueen MJ, Lieske JC, Zakowski JJ, Miller WG. State of the art for measurement of urine albumin: comparison of routine measurement procedures to isotope dilution tandem mass spectrometry. Clin Chem 2014;60:471-80. (Related Editorial: Scott MG, Coyne DW. Clin Chem 2014;60:435-7.)
  • Boyd JC, Bruns DE. Effects of measurement frequency on analytical quality required for glucose measurements in ICUs: assessments by simulation models. Clin Chem 2014;60:644-50. (Related Editorial: Van den Berghe G. Clin Chem 2014;60:577-9).

 

 SELECTED INVITED LECTURES

  • Bruns DE. Optimal Glucose Monitoring. 31st International Symposium on Intensive Care and Emergency Medicine. Brussels, March 22-25, 2011.Bruns DE. Are glucose meters up to the task of TGC? 2011 Arnold O. Beckman Conference. San Diego, April 12-13, 2011.

  • Bruns DE, Boyd JC. POCT Glucose measurement and its limitations. 21st International Congress of Clinical Chemistry and Laboratory Medicine. Berlin, May 15-20, 2011.

  •  Bruns DE. Accuracy requirements for glucose assays used to support intensive insulin therapy. Diabetes Diagnostics. Zwolle, The Netherlands, September 20, 2011.

  • Bruns DE. Glucose Measurements in Critical Care. 32nd International Symposium on Intensive Care and Emergency Medicine. Brussels, March 22-23, 2012.

  • Bruns DE. Labomas. Endocrine Grand Rounds, University of Virginia School of Medicine. October 16, 2012.

  • Bruns DE. Directions in Clinical Chemistry and Laboratory Medicine. Opening Plenary Lecture. IFCC General Conference. Kuala Lumpur, Malaysia. November 17-20, 2012.

  • Bruns DE. Desirable performance for point-of-care glucose measurements in hospital settings. EUROMEDLAB Milano. 20th IFCC-EFCC European Congress of Laboratory Medicine. 45th Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology. Milan, Italy. May 19-23, 2013.

  • Bruns DE.  Hemoglobin A1c as a Diagnostic Tool - Requirements. Latin-American Congress of Clinical Biochemistry. Lima, Peru.  October 29-31, 2013.

  • Bruns DE. Desirable analytical performance of continuous glucose monitors. IFCC WORLDLAB Congress, International Federation of Clinical Chemistry. Istanbul, June 22-26, 2014.

 

    A current list of Dr. Bruns' peer-reviewed publications is available from PubMed.